OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Brain imaging plays an increasingly important role in experimental medicine for dementia by providing biomarkers for diagnosis, prognosis, patient stratification and monitoring treatment response. Imaging can also provide insights into mechanisms of risk and resilience for neurodegeneration. The Translational Neuroimaging Group investigate brain ageing in both health and disease. We have demonstrated that people at increased risk of later developing Alzheimer’s and Parkinson’s disease have particular ‘signatures’ of brain activity. I will introduce some of the methodology and describe how the techniques are being used to improve our understanding of brain ageing.
